Systematic Review and Meta-Analysis of a New Active Transcutaneous Bone Conduction Implant.
bone conduction
cochlear implants
hearing loss
meta analysis
treatment outcome
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
Apr 2024
Apr 2024
Historique:
revised:
10
08
2023
received:
18
11
2022
accepted:
01
09
2023
medline:
18
3
2024
pubmed:
18
9
2023
entrez:
18
9
2023
Statut:
ppublish
Résumé
This review aims to quantify the pooled functional gain (FG) in different types of hearing loss with the transcutaneous hearing device, Osia (Cochlear, Sydney, Australia) in comparison with the unaided state. Secondary outcomes are patient-reported outcomes measures (PROMs) and complication rates. Medline, Embase, SCOPUS, Cochrane CENTRAL, PROSPERO and Cochrane Library. Systematic review and meta-analysis of indexed search terms relating to "Osia," "Osseointegration," "Cochlear Implant," and "Bone-Anchored Prosthesis" was performed from database inception to September 20, 2022. Of the 168 studies identified, 14 studies with 15 patient cohorts (n = 314) met inclusion criteria for meta-analysis. Pooled overall mean FG for all types of hearing loss was 35.0 dB sound pressure level (SPL) (95% confidence interval [CI] 29.12-40.97) compared against unaided hearing. Pooled FG for conductive/mixed hearing loss was 37.7 dB SPL (95% CI 26.1-49.3). Pooled single-sided deafness (SSD) FG could not be calculated due to the small patient cohort for whom SSD data was reported. There is a trend toward improvements in speech receptiveness threshold, signal to noise ratio, and some PROMs compared with baseline hearing. Early complication rates demonstrate risks similar to other transcutaneous implants, with a low predicted explantation (0.11%, 95% CI 0.00%-1.90%) and wound infection rate (1.92% [95% CI 0.00%-6.17%]). No articles directly comparing transcutaneous devices were identified. The Osia devices demonstrate clear audiologic benefits and a good safety profile for the included patient population. Our study results indicate that frequency-specific gain, PROMs, and the audiological benefit in single-sided deafness may be areas for future prospective research. Laryngoscope, 134:1531-1539, 2024.
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1531-1539Informations de copyright
© 2023 The American Laryngological, Rhinological and Otological Society, Inc.
Références
Magele A, Schoerg P, Stanek B, Gradl B, Sprinzl GM. Active transcutaneous bone conduction hearing implants: systematic review and meta-analysis. PloS One. 2019;14(9):e0221484.
Sprinzl GM, Wolf-Magele A. The Bonebridge Bone Conduction Hearing Implant: indication criteria, surgery and a systematic review of the literature. Clin Otolaryngol. 2016;41(2):131-143. https://doi.org/10.1111/coa.12484.
Cushing SL, Gordon KA, Purcell PL, Feness M, Negandhi J, Papsin BC. Surgical considerations for an osseointegrated steady state implant (OSIA2 R) in children. Laryngoscope. 2022;132(5):1088-1092. https://doi.org/10.1002/lary.29892.
Ellsperman SE, Nairn EM, Stucken EZ. Review of bone conduction hearing devices. Audiol Res. 2021;11(2):207-219. https://doi.org/10.3390/audiolres11020019.
Goycoolea M, Ribalta G, Tocornal F, et al. Clinical performance of the Osia™ system, a new active osseointegrated implant system. Results from a prospective clinical investigation. Acta Otolaryngol. 2020;140(3):212-219. https://doi.org/10.1080/00016489.2019.1691744.
Rohani SA, Bartling ML, Ladak HM, Agrawal SK. The BONEBRIDGE active transcutaneous bone conduction implant: effects of location, lifts and screws on sound transmission. J Otolaryngol Head Neck Surg. 2020;49(1):58. https://doi.org/10.1186/s40463-020-00454-1.
Szabo L, Nagy R, Perenyi A, Kiss JG, Rovo L, Bere Z. BAHA Attract-to-Osia conversion patients: comparison of the two systems and long term outcomes. J Laryngol Otol. 2022;137:757-762. https://doi.org/10.1017/S0022215122001839.
Briggs R, Birman CS, Baulderstone N, et al. Clinical performance, safety, and patient-reported outcomes of an active osseointegrated steady-state implant system. Otol Neurotol. 2022;43(7):827-834. https://doi.org/10.1097/MAO.0000000000003590.
Mylanus EAM, Hua H, Wigren S, et al. Multicenter clinical investigation of a new active osseointegrated steady-state implant system. Otol Neurotol. 2020;41(9):1249-1257. https://doi.org/10.1097/mao.0000000000002794.
Souza MA, Vallejos Riart SL, Souza SR, de Brito R, Bento RF. Complications of transcutaneous protheses - a systematic review of publications over the past 10 years. Int Arch Otorhinolaryngol. 2022;26(3):e505-e512. https://doi.org/10.1055/s-0042-1742352.
Marszal J, Gibasiewicz R, Blaszczyk M, Gawlowska M, Gawecki W. Piezoelectric bone conduction hearing implant Osia® - audiological and quality of life benefits. Otolaryngol Pol. 2021;75(6):11-22. https://doi.org/10.5604/01.3001.0014.9342.
Goldstein MR, Bourn S, Jacob A. Early Osia® 2 bone conduction hearing implant experience: nationwide controlled-market release data and single-center outcomes. Am J Otolaryngol. 2021;42(1):102818. https://doi.org/10.1016/j.amjoto.2020.102818.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.
Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. https://doi.org/10.1136/bmj.n160.
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. https://doi.org/10.1186/2046-4053-4-1.
Veritas Health I. Covidence Systematic Review Software, Melbourne Australia. 2020.
Sterne JAC, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https://doi.org/10.1136/bmj.i4919.
Moola S, Munn Z, Tufanaru C, et al. Chapter 7: systematic reviews of etiology and risk - checklist for analytical cross-sectional studies. In: Aromataris EZM, ed. Joanna Briggs Institute Reviewer's Manual. Joanna Briggs Institute; 2017.
Moola S, Munn Z, Tufanaru C, et al. Chapter 7: systematic reviews of etiology and risk - checklist for case series. In: Aromataris EZM, ed. Joanna Briggs Institute Reviewer's Manual. Joanna Briggs Institute; 2017.
McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2020;12:55-61. https://doi.org/10.1002/jrsm.1411.
OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Accessed October 9, 2022. http://www.cebm.net/index.aspx?o=5653.
Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72(1):39. https://doi.org/10.1186/2049-3258-72-39.
Rauch A-K, Wesarg T, Aschendorff A, Speck I, Arndt S. Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia®. Eur Arch Otorhinolaryngol. 2022;279(9):4279-4288. https://doi.org/10.1007/s00405-021-07167-9.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 Statement: an Updated Guideline for Reporting Systematic Reviews. BMJ Publishing Group; 2021.
Lau K, Scotta G, Wright K, et al. First United Kingdom experience of the novel Osia active transcutaneous piezoelectric bone conduction implant. Eur Arch Otorhinolaryngol. 2020;277(11):2995-3002. https://doi.org/10.1007/s00405-020-06022-7.
You P, Choi A, Drob J, Hunsaker SM, Liu Y-CC, Silva R. Early outcomes of a new active transcutaneous bone conduction implant in Pediatric patients. Otol Neurotol. 2022;43(2):212-218. https://doi.org/10.1097/MAO.0000000000003426.
Florentine MM, Virbalas J, Chan DK. Early surgical and audiologic outcomes of active, transcutaneous, osseointegrated bone-conduction hearing device (Osia 2® system) placement. Int J Pediatr Otorhinolaryngol. 2022;156:111114. https://doi.org/10.1016/j.ijporl.2022.111114.
Willenborg K, Avallone E, Maier H, Lenarz T, Busch S. A new active osseointegrated implant system in patients with single-sided deafness. Audiol Neurootol. 2022;27(1):83-92. https://doi.org/10.1159/000515489.
Pla-Gil I, Redó MA, Pérez-Carbonell T, et al. Clinical performance assessment of a new active osseointegrated implant system in mixed hearing loss: results from a prospective clinical investigation. Otol Neurotol. 2021;42(7):e905-e910. https://doi.org/10.1097/MAO.0000000000003116.
Crowder HR, Bestourous DE, Reilly BK. Adverse events associated with Bonebridge and Osia bone conduction implant devices. Am J Otolaryngol Head Neck Med Surg. 2021;42(4):102968. https://doi.org/10.1016/j.amjoto.2021.102968.
Busch S, Willenborg K, Salcher R, Lenarz T, Maier H. First results with the active osseointegrated implant system Osia in patients with single-sided deafness. Laryngorhinootologie. 2021;100(suppl 2):S219. https://doi.org/10.1055/s-0041-1728435.
Deeks JD, Higgins JPT, Altman D. Chapter 10: analysing data and undertaking meta-analyses. In: Deeks JJ, Higgins JPT, Altman DG, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 6.3. Cochrane; 2022. www.training.cochrane.org/handbook.